Today, the National Pharmaceutical Council’s Chief Science Officer, Robert W. Dubois, MD, PhD, will participate in a discussion at the FT US Healthcare & Life Sciences Summit on how the U.S. health system can adapt to afford the next wave of innovative medicines. Through discussion with panelists representing other corners of the health care industry, Dr. Dubois will promote the research-first approach of NPC’s Going Below the Surface initiative for addressing the issue of spending in health care.

We encourage you to follow the conversation at #FTUSHealth and share your thoughts and perspectives using the #GoingBelowTheSurface hashtag.